{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:53:34Z","timestamp":1791078814164,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01AR041325"],"award-info":[{"award-number":["R01AR041325"]}]},{"name":"NIH","award":["5R01AR047838"],"award-info":[{"award-number":["5R01AR047838"]}]},{"name":"NIH","award":["5T32AR007581"],"award-info":[{"award-number":["5T32AR007581"]}]},{"name":"NIH","award":["P30AR046121"],"award-info":[{"award-number":["P30AR046121"]}]},{"name":"Research Facilities Improvement Program","award":["C06RR10601"],"award-info":[{"award-number":["C06RR10601"]}]},{"name":"Research Facilities Improvement Program","award":["C06-RR12538-01"],"award-info":[{"award-number":["C06-RR12538-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bone.2009.11.011","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T10:23:11Z","timestamp":1258539791000},"page":"666-672","source":"Crossref","is-referenced-by-count":103,"title":["Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity"],"prefix":"10.1016","volume":"46","author":[{"given":"Samuel","family":"Gourion-Arsiquaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Burr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Vashishth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele L.","family":"Boskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.bone.2009.11.011_bib1","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1007\/s00198-003-1489-x","article-title":"Bone quality: where do we go from here?","volume":"14","author":"Bouxsein","year":"2003","journal-title":"Osteoporos Int"},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2009.11.011_bib2","article-title":"The role of cortical bone and its microstructure in bone strength","volume":"35","author":"Augat","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.bone.2009.11.011_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1590\/S0004-27302006000400003","article-title":"Bone quality: what is it and how is it measured?","volume":"50","author":"Compston","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.bone.2009.11.011_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11914-006-0002-9","article-title":"Bone geometry and skeletal fragility","volume":"4","author":"Bouxsein","year":"2006","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2009.11.011_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00198-005-2035-9","article-title":"The role of collagen in bone strength","volume":"17","author":"Viguet-Carrin","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/er.2006-0029","article-title":"Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease","volume":"28","author":"Chavassieux","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2009.11.011_bib7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00198-008-0579-1","article-title":"The effect of the microscopic and nanoscale structure on bone fragility","volume":"19","author":"Ruppel","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. fracture intervention trial research group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2009.11.011_bib9","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2009.11.011_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. vertebral efficacy with risedronate therapy (VERT) study group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2009.11.011_bib11","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of postmenopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2009.11.011_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1185\/030079903125002009","article-title":"Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study","volume":"19","author":"Hosking","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bone.2009.11.011_bib13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bone.2009.11.011_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11914-008-0007-7","article-title":"Treatment of premenopausal women with low bone mineral density","volume":"6","author":"Cohen","year":"2008","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2009.11.011_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6604382","article-title":"Risks and benefits of bisphosphonates","volume":"98","author":"Coleman","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2009.11.011_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bone.2003.12.022","article-title":"Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy","volume":"34","author":"Delmas","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s001980070051","article-title":"Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis","volume":"11","author":"Haguenauer","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00198-009-0904-3","article-title":"Is bone quality associated with collagen age?","volume":"20","author":"Leeming","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S8756-3282(97)00279-2","article-title":"Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance","volume":"22","author":"Knott","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0021-9290(95)00048-8","article-title":"The effects of ageing and changes in mineral content in degrading the toughness of human femora","volume":"29","author":"Currey","year":"1996","journal-title":"J Biomech"},{"key":"10.1016\/j.bone.2009.11.011_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002239900683","article-title":"Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength","volume":"65","author":"Bailey","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2009.11.011_bib22","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1359\/jbmr.2001.16.10.1821","article-title":"Spectroscopic characterization of collagen cross-links in bone","volume":"16","author":"Paschalis","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1359\/jbmr.090201","article-title":"Spatial variation in osteonal bone properties relative to tissue and animal age","volume":"24","author":"Gourion-Arsiquaud","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jbiomech.2008.02.017","article-title":"Failure of mineralized collagen fibrils: modeling the role of collagen cross-linking","volume":"41","author":"Siegmund","year":"2008","journal-title":"J Biomech"},{"key":"10.1016\/j.bone.2009.11.011_bib25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The alendronate phase III osteoporosis treatment study group","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2009.11.011_bib26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2009.11.011_bib27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1359\/jbmr.1998.13.11.1721","article-title":"Human osteoclast formation and activity in vitro: effects of alendronate","volume":"13","author":"Breuil","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-007-0462-5","article-title":"Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies","volume":"19","author":"Byrjalsen","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00198-008-0725-9","article-title":"Spectroscopic markers of bone quality in alendronate-treated postmenopausal women","volume":"20","author":"Boskey","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00198-007-0533-7","article-title":"Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra","volume":"19","author":"Allen","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00198-008-0585-3","article-title":"Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs","volume":"19","author":"Saito","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bone.2003.08.004","article-title":"Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs","volume":"33","author":"Burr","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib34","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","article-title":"Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate","volume":"39","author":"Allen","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S8756-3282(01)00575-0","article-title":"Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures","volume":"29","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1359\/jbmr.2003.18.3.512","article-title":"Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra","volume":"18","author":"Komatsubara","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-008-0754-4","article-title":"Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate","volume":"20","author":"Tang","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib39","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1359\/jbmr.060401","article-title":"Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women","volume":"21","author":"Zoehrer","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-59745-104-8_20","article-title":"Fourier transform-infrared microspectroscopy and microscopic imaging","volume":"455","author":"Gourion-Arsiquaud","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bone.2009.11.011_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.vibspec.2005.02.015","article-title":"Infrared spectroscopic characterization of mineralized tissues","volume":"38","author":"Boskey","year":"2005","journal-title":"Vib Spectrosc"},{"key":"10.1016\/j.bone.2009.11.011_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/BCO.0b013e3282b97133","article-title":"Fourier transform infrared and Raman microspectroscopy and microscopic imaging of bone","volume":"18","author":"Gourion-Arsiquaud","year":"2007","journal-title":"Curr Opin Orthop"},{"key":"10.1016\/j.bone.2009.11.011_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S8756-3282(99)00276-8","article-title":"Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment","volume":"26","author":"Bohic","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S8756-3282(01)00661-5","article-title":"Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats","volume":"30","author":"Bourrin","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.orthres.2003.05.001","article-title":"Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties","volume":"22","author":"Day","year":"2004","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2009.11.011_bib46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib47","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jbm.a.31599","article-title":"Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro","volume":"84","author":"Henneman","year":"2008","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.bone.2009.11.011_bib48","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1359\/jbmr.060701","article-title":"Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate","volume":"21","author":"Durchschlag","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib49","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00198-006-0155-5","article-title":"Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN\/Kob rats","volume":"17","author":"Saito","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1359\/jbmr.1999.14.9.1473","article-title":"On the estrogen\u2013bone relationship and postmenopausal bone loss: a new model","volume":"14","author":"Frost","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib51","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1359\/jbmr.060904","article-title":"Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women","volume":"21","author":"Szulc","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2009.11.011_bib52","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/adc.2003.036590","article-title":"Bisphosphonate treatment of bone disease","volume":"90","author":"Shaw","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bone.2009.11.011_bib53","first-page":"87","article-title":"Bisphosphonate treatment of pediatric bone disease","volume":"3","author":"Speiser","year":"2005","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.bone.2009.11.011_bib54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1115\/1.2895536","article-title":"A 20-year perspective on the mechanical properties of trabecular bone","volume":"115","author":"Keaveny","year":"1993","journal-title":"J Biomech Eng"},{"key":"10.1016\/j.bone.2009.11.011_bib55","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.jbiomech.2008.07.009","article-title":"Biomechanical effect of mineral heterogeneity in trabecular bone","volume":"41","author":"Renders","year":"2008","journal-title":"J Biomech"},{"key":"10.1016\/j.bone.2009.11.011_bib56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2004.10.006","article-title":"Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse","volume":"36","author":"Misof","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.11.011_bib57","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2009.11.011_bib58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MED.0b013e328317ca83","article-title":"Osteoporosis: how long should we treat?","volume":"15","author":"Sebba","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.bone.2009.11.011_bib59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-009-0003-6","article-title":"Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment","volume":"7","author":"Geusens","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2009.11.011_bib60","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","article-title":"Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate","volume":"358","author":"Lenart","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2009.11.011_bib61","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","article-title":"Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study","volume":"20","author":"Lenart","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib62","article-title":"Unusual mid-shaft fractures during long term bisphosphonate therapy","author":"Odvina","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl. 5","key":"10.1016\/j.bone.2009.11.011_bib63","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1007\/s00198-003-1477-1","article-title":"Role of bone turnover in microdamage","volume":"14","author":"Schaffler","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2009.11.011_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jbiomech.2007.10.020","article-title":"Modeling the onset and propagation of trabecular bone microdamage during low-cycle fatigue","volume":"41","author":"Kosmopoulos","year":"2008","journal-title":"J Biomech"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209020237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209020237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T23:58:29Z","timestamp":1544831909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328209020237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S8756328209020237"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.11.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}